awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28067556-58093F85-7CF5-4BB9-A6D9-6443F329889F
Q28067556-58093F85-7CF5-4BB9-A6D9-6443F329889F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28067556-58093F85-7CF5-4BB9-A6D9-6443F329889F
Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer
P2860
Q28067556-58093F85-7CF5-4BB9-A6D9-6443F329889F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28067556-58093F85-7CF5-4BB9-A6D9-6443F329889F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e24654b035bdb2f4d8908a5cabfdb91307f376c1
P2860
Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.